针对IKs通道PKA酸化轴,以恢复其在高风险LQT1变种中的功能
Ling Zhong1,2, Zhenzhen Yan1,2, Dexiang Jiang1,2
1Dr. Neher's Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Taipa, Macao SAR, China (L.Z., Z.Y., D.J., Y.O., H.Z., X.L., C.X., C.H., B.S., S.K.C., Z.-H.J., E.N., P.H.).
Circulation research
|August 21, 2024
概括
研究人员确定了KCNQ1+KCNE1 (IKs) 通道中的PKA酸化轴,这对心脏应激适应至关重要. 一种名为ML277的药物通过准这一轴来拯救高风险的LQT1变异,提供一种潜在的抗失常策略.
科学领域:
- 心血管生理学心血管生理学
- 分子心脏病学分子心脏病学
- 离子通道功能的功能
背景情况:
- KCNQ1+KCNE1 (IKs) 通道通过循环腺单酸盐 (cAMP) /蛋白激酶A (PKA) 路径酸化调节心脏适应压力.
- 在KCNQ1的变体导致长QT综合征类型1 (LQT1),有缺陷的cAMP效应增加心脏骤停的风险.
- 在高风险突变中,IKs酸化和功能以及cAMP敏感性丧失之间的精确分子联系仍然不清楚.
研究的目的:
- 通过PKA酸化阐明IKs通道调节的分子决定因素.
- 调查LQT1变体中确定的酸化部位的临床相关性.
- 确定高风险LQT1突变的潜在治疗策略.
主要方法:
- 利用补丁和电压的光测量来研究野生类型和突变的KCNQ1/IKs通道.
- 分析了LQT1突变的临床表型透率,以评估风险.
- 采用患者特异性诱导多能干细胞模型来验证机械学的发现.
主要成果:
- 确定了形成IKs通道PKA酸化轴的关键残留物,跨越N端到中央孔隙.
- 发现高透率的LQT1变体沿着这种酸化轴聚集,证实了临床相关性.
- 证明ML277,一个针对轴中心的小分子,在高风险的LQT1变体中挽救cAMP缺陷,并减轻患者衍生的心肌细胞中的异常.
结论:
- 阐明了依赖PKA的IKs通道酸化的分子机制.
- 确定了IKs通道PKA酸化轴作为通道功能和LQT1风险的关键决定因素.
- 提供了ML277作为高风险LQT1患者潜在的抗心律失常治疗策略的证据.
相关概念视频
01:22PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.2K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.2K
01:22Amplifying Signals via Enzymatic Cascade
8.4K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.4K
01:26Receptor Tyrosine Kinases
12.5K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
12.5K
02:54Protein Kinases and Phosphatases
13.1K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.1K